First Test That Predicts Severe Outcomes In COVID-19 Patients Receives CE Mark
MeMed’s test measures immune system response to assess a patient’s COVID-19 trajectory.
You may also be interested in...
Sensyne obtained UK regulatory approval for its SYNE-COV machine learning algorithm to assess the long-term risks of COVID-19.
Results showed that patients were less likely to exhibit disease progression, or die, following treatment with beta-emitted microspheres.
A pilot study of the augmented reality system suggests it improves the precision of knee arthroplasty surgery.